Wegovy: Promising Results in Clinical Trial Show Significant Reduction in Cardiovascular Risk
A major clinical trial revealed that the weight loss drug Wegovy reduced the risk of heart attack, stroke, or heart-related death by 20% for people with cardiovascular disease. Doctors said the findings, which have not yet been peer-reviewed or published in a medical journal, may encourage more people to use the popular weight-loss drug. According … Read more
